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Conclusions: Arg16Gly and Gln27Glu polymorphisms in the gene 
encoding Beta-2 Adrenergic Receptor (ADRB2) may be risk factors for 
reduced bone mineral density in females.
P03 -IDENTIFICATION OF NEUROPATHIC PAIN 
COMPONENT IN PATIENTS OF VARIOUS AGE WITH KNEE 
OSTEOARTHRITIS
V.V. Povoroznyuk, U.I. Pryimych
D.F. Chebotarev Institute of Gerontology NAMS Ukraine, Kyiv, 
Ukraine.
Introduction: Osteoarthritis-induced pain is a result of nocicep-
tor stimulation, associated with local tissue damage and inflamma-
tion. Resent data suggest the presence of neuropathic pain symptoms 
in patients with osteoarthritis.
Objectives: The aim of this study was to estimate the structure of 
pain syndrome, reveal the presence of neuropathic pain (NP) compo-
nent, symptoms and signs of NP in patients suffering from knee os-
teoarthritis.
Methods: We’ve examined 44 patients with knee osteoarthritis 
of the II-III stages by the Kallgren-Lawrence scale aged 47-85 years 
(average age 66.1 ± 1.5 years). To assess the NP component, we used 
screening scales painDETECT, LANSS, DN4 questionnaires. To assess 
intensity of pain, visual analogue scale (VAS) was used. Besides 
 WOMAC and EuroQol-5D questionnaire were applied. For statistical 
analysis of results, ANOVA, correlation and regression analysis was 
applied.
Results: 4.6% of patients with knee osteoarthritis examined by 
painDETECT were likely to have the NP component. LANSS scale: 25% 
were probably to have NP. DN4 scale: 31.2% probably had NP. Moder-
ate to significant correlations were found between intensity of pain 
by VAS data and Neuropathic Pain Scales (painDETECT, LANSS, DN4) 
data (p < 0.05). It was established that higher results of screening by 
painDETECT and DN4 positively correlate with a disturbance of 
physical function tested by WOMAC (p < 0.05). PainDETECT data 
have moderate to significant correlations with EuroQol-5D question-
naire (p < 0.01). Verbal descriptors as pins and needles, tingling, 
numbness and allodynia, pain from light touch which are revealed 
by 3 screening scales can significantly contribute to the likely neu-
ropathic component in patients with knee osteoarthritis (p < 0.05). 
Burning pain (p < 0.01), pins and needles (p < 0.05) can be associated 
with a more severe pain in patients with knee osteoarthritis.
Conclusions: Thus, in patients with osteoarthritis the pain syn-
drome may reveal NP features. Identification of these would promote 
a targeted treatment strategy.
P04. EVALUATION OF BONE MINERAL DENSITY 
IN ADOLESCENTES WITH ANOREXIA NERVOSA
Patrícia Gouveia, Ricardo Teixeira, Rui Brito, Rosa Castro, 
Inês Amorim
Medicina Nuclear.
Introduction: One of Anorexia Nervosa’s (AN) most frequent 
complications is the loss of bone mass, which represents a serious 
problem in adolescence, as it may reduce the peak bone mass at-
tained, leading to osteopenia and osteoporosis.
Objectives: The objective of our study was to evaluate the preva-
lence of the reduction of Bone Mineral Density (BMD) in adolescents 
with AN, and its relation to anthropometric data (weight, height and 
BMI).
Methods: 66 adolescents with AN, referred to the Santo António 
Hospital Nuclear Medicine service between 2008 and 2015, were 
retrospectively studied. A Hologic QDR-4500 densitometer was used 
to calculate BMD, Z-score and BMC. The correlation between vari-
ables was determined by linear regression analysis. The significance 
level was established at p ≤ 0,05.
Results: The studied population presented average values of 0.86 
± 0.11 g/cm2 of BMD, -0.67 ± 1.21 of Z-score and 26.82 ± 15.05 g of 
BMC. 14% of patients presented with bone mineralisation values be-
low the variation expected for the age (Z-score < -2), it being that 40% 
of patients had a reduction of bone mass, defined, in this study, by a 
Z-score < -1. Further, there was a significant correlation between the 
anthropometric data and bone mineral density, more notorious in 
relation to weight and to BMC.
Conclusions: The results showed that, in an adolescent popula-
tion with AN, more than half of the individuals show no significant 
changes in BMD. These results are similar to those of previous stud-
ies and demonstrate that, in the disease’s initial stages, BMD is rela-
tively maintained. This study stresses the importance of early 
diagnosis of AN in adolescents, so as to find strategies to prevent loss 
of bone mass in this age group and impede the reduction in peak 
bone mass expected, which could leave to future severe complica-
tions.
P05. OSTEOPOROSIS IN NEUROLOGICAL DISORDERS
Vladyslav Povoroznyuk, Maryna Bystrytska, Iryna Karaban, 
Nina Karasevych
Institute of Gerontology NAMS Ukraine, Kyiv, Ukraine.
Introduction: Neurological disorders, notably stroke, Parkinson’s 
disease and spinal cord injury are associated with increased falls risk 
and fracture risk.
Objectives: The aim of the research is to define the bone mineral 
density in patients, with neurological disorders.
Methods: We examined 48 men and women with Parkinson’s 
disease (duration of Parkinson’s disease was at list 5 years and all 
were on L-dopa treatment), 52 stroke patients (men and women), 
21 patients with chronic spinal cord injury (AIS score A, B) and 
healthy people of appropriate age.
Results: BMD of patients with Parkinson’s disease was signifi-
cantly lower compared with BMD of healthy persons, both men and 
women (BMD lumbar spine women = 1.00 ± 0.15 vs 1.11 ± 0.15 g/cm2, 
p < 0.05, the difference of BMD was about 15%, and BMD lumbar 
spine men = 1.16 ± 0.24 vs 1.29 ± 0.24 g/cm2, p < 0.05). BMD stroke 
patients was also significantly lower compared with BMD of healthy 
persons: (BMD lumbar spine = 1.13 ± 0.20 vs 1.28 ± 0.46 g/cm2, 
p < 0.05, BMD total hip = 0.97 ± 0.18 vs 1.09 ± 0.25 g/cm2, p < 0.05). In 
women the difference was significant at the level of the total body 
and distal forearm. In men, the difference was significant only in the 
group of the patients with moderate and severe paresis. BMD SCI 
patients was dramatically low (BMD lumbar spine = 1.14 ± 0.19 vs 
1.24 ± 0.26 g/cm2, p < 0.05, BMD total hip = 0.82 ± 0.28 vs 1.07 ± 
0.27 g/cm2, p < 0.05), the difference of BMD was about 23%.
Conclusions: BMD in men and women with neurological disor-
ders (Parkinson’s disease, stroke and spinal cord injury) was signifi-
cantly lower than in healthy persons of the same age.
P06. EVIDENCE OF ISOFLAVONES USE IN OSTEOPOROSIS 
PREVENTION
Ângela Lee Chin, Ana Filipa Vicente, Olena Berezovska Lourenço
Medicina Geral e Familiar.
Osteoporosis is characterized by decreased bone mass and mi-
croarchitectural deterioration of bone, increasing fracture risk. 
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Menopause is a risk factor, in long term, to the increased incidence 
of osteoporosis. Attending to this subject importance, and in order 
to determinate the level of evidence of isoflavones prescription in 
osteoporosis prevention in postmenopausal women, it was consid-
ered pertinent the preparation of this review. We performed a liter-
ature search in databases of National Guideline Clearinghouse, 
Cochrane Library, Canadian Medical Association Practice Guidelines 
InfoBase, DARE, Bandolier, Evidence based Medicine online and 
Pubmed in the last decade studies in English and Portuguese, using 
the terms MeSH: “Isoflavones” and “Bone Density.” For stratified the 
level of evidence and strength of recommendation, the SORT scale of 
the American Academy of Family Physicians was used. Inclusion cri-
teria: PICO (Population: postmenopausal women; Intervention: 
isoflavones; Comparison: other treatments or no one; Outcome: pre-
vention of decreased bone density). 282 articles were founded and 
11 were selected for review, including 4 meta-analyzes, 3 systematic 
reviews and 4 randomized controlled trials. Analyzed studies re-
vealed the existence of controversy in this subject. One meta-analy-
sis and 3 systematic review concluded that isoflavones may prevent 
osteoporosis in postmenopausal women, however this effect will 
depend on factors such as the dose, the treatment duration and the 
time since menopause. It is also necessary to consider possible inter-
actions between isoflavones and anti-osteoporotic drugs, so it is 
premature to recommend the prescription of these supplements. 
A meta-analysis was inconclusive. 4 clinical trials and 2 meta-ana-
lyzes concluded there is no benefit in supplementation with isofla-
vones in the prevention of osteoporosis. With this review we 
concluded that isoflavones may have some effect in preventing oste-
oporosis but there is insufficient evidence to justify their prescrip-
tion for this purpose (level of evidence 1, grade A of recommendation).
P07. EARLY MENOPAUSE AND DECLINE OF BONE 
MINERAL DENSITY – A CLINICAL REPORT
Ângela Lee Chin, Ana Filipa Vicente, Olena Berezovska Lourenço
Medicina Geral e Familiar.
Osteoporosis is the most common bone disease characterized by 
increased loss of bone mass and deterioration of its microstructure, 
increasing the risk of fracture. There are multiple risk factors for its 
development, particularly affecting women after menopause. We 
report the case of 35 years old woman that came to our general prac-
tice consultation in January 2016, with complaints of intense back 
pain and low back pain without irradiation, with months of evolu-
tion, without history of previous trauma and pain with mechanical 
characteristics. From her case history stands out: early menopause 
when she was 21, secondary to chemotherapy and radiation therapy 
due to invasive ductal carcinoma of the breast in 2001; Acute lym-
phoblastic leukemia in 2006 followed by new chemotherapy, radia-
tion therapy, long term corticosteroid therapy and bone marrow 
transplant in 2007; bilateral hip prosthesis after aseptic necrosis in 
2008, with dysmetria of members. She remains being followed by 
Oncology. Bone densitometry in 2015 compatible with osteopenia, 
having as chronic medication calcium and cholecalciferol. On the 
objective examination, is observed limbing, without pain on palpa-
tion of the spinous process of vertebra or others changes. We pre-
scribed topical anti-inf lammatory, oral muscle relaxant and 
analgesic therapy. The radiography of column and bilateral hip ex-
cluded osteoporotic fractures. The osteoarticular complaints in this 
context could be attributed to an osteoporotic fracture, and bone 
metastasis, but this probability is reduced by frequent follow-up in 
oncology. Considering to early menopause and osteopenia, it is indi-
cated supplementation with calcium and vitamin D. Furthermore, 
hormone replacement therapy is contra-indicated in this patient. 
The family doctor, with his holistic approach and continuity of care, 
is essential in the early detection of the disease, taking into account 
the risk factors of this patient, and also in reinforcement of the im-
plementation of long-term preventive measures (pharmacological 
and non-pharmacological).
P08. EPIDEMIOLOGY OF LOWER LIMB FRACTURES 
IN UKRAINIAN POPULATION
Nataliia Grygorieva, Volodymyr Vayda, Roman Vlasenko, 
Ostap Zubach
Institute of Gerontology named D.F. Chebotarev NAMS Ukraine.
Introduction: Fractures are a considerable public health burden 
but information on their epidemiology in Ukraine is limited.
Objectives: The aim of the study was to establish the incidence of 
lower limb fractures in Ukrainian population.
Methods: We identified 665 subjects from 76,765 citizens, living 
in Vinnitsa region, who had a first time (incident) diagnosis of lower 
limb fractures recorded in the regional Hospital database from 
1.01.2011 to 31.12.2011.
Results: Frequency the lower limb fractures of was 42.4% from 
the total fractures in all patients and 44.4% from the total fractures 
in patient aged 50 years and older. The most common anatomic site 
of lower limb fractures was the tibia and/or fibula (48.9% of all inci-
dent lower limb fractures), followed by the hip (29.5%), and the tar-
sal/metatarsal bones (21.6%). Incidence of fracture in patient 50 years 
and old was 519.8 per 10,000 patient for lower limb fractures, 212.3 
per 10,000 patient for tibia and/or fibula fractures and 226.9 per 
10,000 patient for hip fracture, Lower limb fractures were more com-
mon among males than among females in the younger age groups 
(up to 39 years old). Among subjects 50 years and older the incidence 
of lower limb fractures was higher in women than in men, and the 
difference increased with increasing age. Incidence of the tibia and/
or fibula fractures was 340.7 per 10,000 patient in the age group 60-
69 years old, 44.9 per 10,000 patient in age group 70-79 years old, 
and 102.4 per 10,000 patient in age group 80-89 years old.
Conclusions: Our study provided the new information about the 
epidemiology of lower limb fractures in Ukrainian population ac-
cording the age. This information is important for planning of the 
prevention and treatment strategy in patients of different ages.
P09. FEMORAL FRACTURE, REALITY IN A FAMILY HEALTH 
UNIT
Ana Sara Rodrigues, Rita Gomes
Medicina Geral e Familiar.
Introduction: Osteoporosis is characterized by low bone mass 
and deterioration of bone microarchitecture, weakening the bone 
and increasing the risk of fracture. Post-menopausal women and el-
derly men and women are the groups which are at greater risk of 
suffering from osteoporotic fractures.
Objectives: To assess the prevalence of hip fracture at the Family 
Health Unit and verify the indication for bone osteodensitometria.
Methods: Cross-sectional study. We analyzed all patients coded 
with the diagnosis of hip fracture (L75 coding) during the year of 
2015. The data were obtained from the MIM@UF program.
Results: In the year of 2015, a total of 13 patients were coded with 
femoral fracture, with a prevalence of 0.13%. Regarding the sample 
of users, 4 were males and 9 of the patients were female. Patients 
were between 57 and 105 years old, with an average age of 83.7 years. 
Of the total patients evaluated, none previously had a bone oste-
odensitometria prescription or pharmacological treatment with 
anti- resorptive therapy.
